Home/Filings/4/0001250853-15-000108
4//SEC Filing

Lion Biotechnologies, Inc. 4

Accession 0001250853-15-000108

$IOVACIK 0001425205operating

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 3:00 PM ET

Size

7.2 KB

Accession

0001250853-15-000108

Insider Transaction Report

Form 4
Period: 2015-09-30
Bender James G.
Vice President, Manufacturing
Transactions
  • Tax Payment

    Common Stock

    2015-09-30$5.76/sh11,274$64,93888,726 total
  • Award

    Stock Option (right to buy)

    2015-12-28+27,62227,622 total
    Exercise: $7.58Exp: 2025-12-27Common Stock (27,622 underlying)
Footnotes (1)
  • [F1]One third of the shares underlying the option shall vest on December 28, 2016; and the remaining shares shall vest in eight equal quarterly installments over the next two years after the first anniversary of the grant date of December 28, 2015, provided the Reporting Person is still providing services to the Issuer on the respective dates.

Issuer

Lion Biotechnologies, Inc.

CIK 0001425205

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001425205

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 3:00 PM ET
Size
7.2 KB